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Abstract: 
 
Current clinical and epidemiological research provides support for a continuum of bipolar 
psychopathology: a bipolar spectrum that ranges from subthreshold characteristics to clinical 
disorders. The present research examined risk for bipolar spectrum psychopathology at a 3-year 
follow-up assessment in a nonclinically ascertained sample of 112 young adults identified by the 
Hypomanic Personality Scale (HPS). Participants completed diagnostic interviews assessing 
bipolar psychopathology, borderline personality traits, substance use disorders, impulsivity, and 
psychosocial functioning. At the original assessment, 18 of the 112 participants met criteria for a 
bipolar spectrum disorder. At the follow-up, an additional 13 had developed bipolar spectrum 
disorders. A total of 58% of participants scoring in the upper quartile of the HPS qualified for 
bipolar spectrum disorders at the follow-up, including 27% with DSM–IV–TR disorders. The 
HPS predicted new cases and total number of cases of bipolar spectrum disorders, as well as total 
number of DSM–IV–TR bipolar disorders. The HPS also predicted hyperthymic temperament or 
history of hypomania, grandiose traits, impulsivity, substance use disorders, psychosocial 
impairment, and borderline traits. The majority of these effects were significant after removing 
participants with DSM–IV–TR bipolar disorders from the analyses, suggesting that the results 
were not driven by a subset of participants with clinical disorders. Overall, these results offer 
further support for the bipolar spectrum construct and the predictive validity of the HPS as a 
measure of bipolar spectrum psychopathology. 
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Article: 
 
Current clinical and epidemiological research provides support for a broad spectrum of bipolar 
psychopathology (e.g., Akiskal et al., 2000; Alloy, Urošević, et al., 2012; Angst et al., 2003; 
Paris, 2009; Phelps, Angst, Katzow, & Sadler, 2008; Vieta & Phillips, 2007). The bipolar 
spectrum includes, but extends beyond, the boundaries of the Diagnostic and Statistical Manual 
of Mental Disorders, 5th Edition (DSM-5; American Psychiatric Association, 2013). The 
Hypomanic Personality Scale (HPS; Eckblad & Chapman, 1986) appears to offer a promising 
point of entry for studying the bipolar spectrum construct. The present research involved a 3-year 
follow-up assessment of risk for bipolar spectrum psychopathology in young adults who 
completed the HPS at a comprehensive cross-sectional assessment (see Walsh, Royal, Brown, 
Barrantes-Vidal, & Kwapil, 2012; Walsh, Royal, Barrantes-Vidal, & Kwapil, 2012). 
 
The Bipolar Spectrum 
 
Bipolar disorder has been ranked by the World Health Organization (2008) as one of the top 10 
causes of disability worldwide and is associated with premature mortality, largely resulting from 
suicide and accidental death (Ösby, Brandt, Correia, Ekborn, & Sparen, 2001). Traditionally, 
bipolar disorders are estimated to affect approximately 1–2% of the population (Pini et al., 
2005). However, epidemiological studies suggest that this estimate is conservative and discounts 
the growing evidence for a continuum of bipolar spectrum psychopathology (Angst, 1998; Angst 
et al., 2003, 2010; Hoertel, Le Strat, Angst, & Dubertret, 2013; Merikangas et al., 2007; 
Zimmermann et al., 2009). Akiskal and colleagues (2000) estimated that the bipolar spectrum 
characterizes approximately 5% of the general population. Furthermore, epidemiological studies 
report prevalence ranges from 4–14% in community samples (Angst et al., 2010; Hoertel et al., 
2013; Merikangas et al., 2007; Zimmermann et al., 2009), depending on how the bipolar 
spectrum is defined. There is considerable support that subthreshold bipolar psychopathology 
precedes the development of clinical bipolar disorders, with evidence from community samples 
(Beesdo et al., 2009; Zimmermann et al., 2009), high-risk college samples (Alloy, Urošević, et 
al., 2012; Kwapil et al., 2000), and clinical samples (Akiskal, Djenderedjian, Rosenthal, & 
Khani, 1977; Birmaher et al., 2009; Kochman et al., 2005). Moreover, several studies (Angst et 
al., 2003, 2010; Hoertel et al., 2013; Merikangas et al., 2007; Zimmermann et al., 2009) found 
that subthreshold bipolar disorders were associated with maladaptive consequences (e.g., role 
impairment, suicide risk, substance use disorders)—suggesting that the consequences of 
bipolarity apply to subthreshold presentations. 
 
The Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM–
IV–TR; American Psychiatric Association, 2000) included four bipolar disorders: bipolar I 
disorder, bipolar II disorder, cyclothymic disorder, and bipolar disorder not otherwise specified. 
In light of the growing evidence for clinically relevant subthreshold bipolar presentations, the 
task force for the DSM-5 added several bipolar spectrum presentations. Furthermore, numerous 
alternative categorical formulations have been proposed (e.g., Akiskal, 1983, 1996, 2004; 
Akiskal & Akiskal, 1988; Akiskal & Mallya, 1987; Akiskal & Pinto, 1999; Angst et al., 2003; 
Klerman, 1987). One of the most widely considered has been Akiskal’s (2004) model, which 
includes affective temperaments. In addition to bipolar I and II disorders, Akiskal proposed 
bipolar II-1/2 (major depression superimposed on cyclothymic temperament), bipolar III (major 
depression plus hypomania occurring in association with antidepressant or other somatic 
treatment), and bipolar IV (major depression superimposed on hyperthymic temperament). 
Consistent with the DSM-5, Akiskal’s conditions represent discrete diagnostic categories. 
Expanding the diagnostic criteria beyond categorical boundaries, however, has important 
implications for understanding the etiology, potential developmental trajectories, and treatment 
of mood disorders. For example, examining subthreshold characteristics of bipolar disorder may 
identify individuals at risk for clinical disorders, promote early interventions and monitoring, and 
increase the likelihood of patients receiving appropriate treatment (Angst & Cassano, 2005). 
Furthermore, increased research on these subthreshold characteristics may elucidate specific risk 
and protective factors. Greater attention to subclinical bipolarity in clinical practice should also 
encourage focus on minimizing the severity and frequency of episodes, and treating symptoms 
and impairment, rather than specific diagnoses. In summary, we define the bipolar spectrum as a 
continuum of clinical and subclinical expression that includes traditional DSM disorders, 
Akiskal’s expanded diagnoses, and subthreshold forms of hypomanic symptoms. 
 
Regardless of how they are defined, bipolar disorders are characterized by changes in mood, 
energy, cognition, and behavior. Impulsivity is also considered to be a core feature of bipolar 
psychopathology (American Psychiatric Association, 2000). Individuals with bipolar disorders 
often have elevated rates of impulsivity, regardless of whether they are in a depressed (Peluso et 
al., 2007), manic (Swann, Pazzaglia, Nicholls, Dougherty, & Moeller, 2003), or euthymic mood. 
However, the role of impulsivity in the broader bipolar spectrum is less understood. 
 
Assessment of Bipolar Spectrum Psychopathology 
 
Several measures have been developed to screen for risk for bipolar disorders, including the self-
report Temperament Evaluation of Memphis, Pisa, Paris, and San Diego-Autoquestionnaire 
(TEMPS-A; Akiskal, Akiskal, Haykal, Manning, & Connor, 2005) and the General Behavior 
Inventory (GBI; Depue et al., 1981). The TEMPS-A is based on interview evaluations of 
affective temperaments and has been validated in both clinical (Evans et al., 2005) and 
nonclinical samples (Morvan et al., 2011). The GBI successfully identifies subclinical and 
clinical bipolar symptoms in psychiatric outpatient (Depue & Klein, 1988) and nonclinical 
(Depue et al., 1981; Klein, Depue, & Slater, 1985) populations; however, the scale focuses 
primarily on dysthymic and cyclothymic symptoms (Mallon, Klein, Bornstein, & Slater, 1986) 
and may fail to detect individuals at risk for bipolar disorders who exhibit hypomanic 
characteristics. 
 
Eckblad and Chapman (1986) developed the self-report HPS to tap traitlike hypomanic 
functioning. They assessed the validity of the HPS in a cross-sectional study of college students. 
Approximately 77% of high HPS scorers met criteria for a hypomanic episode, whereas no 
control participants received the diagnosis. High HPS scorers also exceeded the control group on 
week-long depressive episodes, diagnoses of cyclothymic disorder, and treatment of 
psychopathology, and reported significantly higher alcohol and drug use. Kwapil et al. (2000) 
conducted a 13-year follow-up of this sample and found that the HPS group surpassed the 
control group on rates of hypomania within the past two years, lifetime bipolar disorders, major 
depressive episodes, substance use disorders, and borderline personality traits. 
 
Numerous other studies have contributed to the construct validation of the HPS. For example, 
research has further examined the association of the HPS with bipolar disorders (Meyer & 
Hautzinger, 2003), development of bipolar symptoms (Blechert & Meyer, 2005), mood 
fluctuations in daily life (Hofmann & Meyer, 2006), impulsivity (Johnson, Carver, Mulé, & 
Joorman, 2013), alcohol use (Meyer & Wolkenstein, 2010), and the behavioral activation system 
(Johnson, Ruggero, & Carver, 2005; Jones & Day, 2008). Few studies, however, have focused 
specifically on the relation of the HPS with the broader bipolar spectrum. 
 
Walsh, Royal, Brown, et al. (2012) examined the construct validity of the HPS as a measure of 
bipolar spectrum psychopathology in the laboratory and in daily life using experience sampling 
methodology (ESM) in a sample of 145 college students oversampled for elevated HPS scores. 
HPS scores were associated with interview-based diagnoses of DSM–IV–TR bipolar disorders, 
Akiskal’s (2004) bipolar spectrum disorders, and hyperthymic temperament or history of 
hypomania. Fifteen (10%) of the participants met criteria for a DSM–IV–TR bipolar disorder 
(three with bipolar I, six with bipolar II, one with cyclothymic, and five with bipolar NOS 
disorders). Seven additional participants qualified for bipolar spectrum disorders. Note that 20 of 
the 22 participants with diagnosable bipolar spectrum disorders scored at least 1.5 SD above the 
mean on the HPS. HPS scores were not significantly associated with history of major depressive 
episodes (despite the fact that major depressive episodes were part of many of the cases of 
bipolar disorders), suggesting that the HPS was specifically associated with bipolar 
psychopathology and not broadly with any mood impairment. HPS scores were associated with 
current depressive symptoms, psychosocial impairment, cyclothymic temperament, impulsivity, 
and borderline personality traits. In daily life, HPS scores predicted negative affect, thought 
disturbance, risky behavior, and measures of grandiosity. These findings remained independent 
of DSM–IV–TR bipolar disorders, suggesting that the results were not due simply to a subset of 
participants with clinical conditions. However, Walsh, Royal, Brown, et al.’s (2012) findings 
were limited to cross-sectional comparisons. Longitudinal assessment is needed to more fully 
understand risk for development of bipolar spectrum psychopathology. 
 
Goals and Hypotheses 
 
The present research continued the validation work of Walsh, Royal, Brown, et al. (2012) by 
examining risk for bipolar spectrum psychopathology in a 3-year longitudinal study of their 
original sample. This work also built on Kwapil et al.’s (2000) longitudinal study by examining a 
broader range of bipolar spectrum psychopathology. It was hypothesized that the HPS would 
predict DSM–IV–TR bipolar disorders, bipolar spectrum disorders, and hyperthymic 
temperament or hypomania. It was expected that these associations would remain significant 
after removing participants who had been diagnosed with the predicted criterion at the initial 
assessment (to allow for examination of new cases). For example, it was expected that the HPS 
would predict bipolar spectrum disorders in the total sample and after removing individuals who 
met criteria for bipolar spectrum disorders at the initial assessment. The HPS was also expected 
to predict hyperthymic temperament characteristics, psychosocial impairment, grandiose traits, 
impulsivity, borderline personality traits, as well as substance use and impairment. These 
predictions were expected to remain significant after removing participants with DSM–IV–TR 
bipolar disorders, consistent with a spectrum model. The HPS was not hypothesized to predict 
major depressive disorder. 
 
Method 
 
Participants 
Selection of participants at the initial assessment 
 
All of the candidate participants for the present study took part in Walsh, Royal, Brown, et al.’s 
(2012) cross-sectional assessment. Approximately 1,200 students enrolled in psychology courses 
completed the HPS in mass-screening sessions. All of the mass-screening participants who 
scored at least 1.5 SD above the mean on the HPS and a comparable number of randomly 
selected participants who scored less than 1.5 SD above the mean were invited to participate in 
the initial assessment. This recruitment strategy was designed to ensure that a sufficient number 
of participants with elevated HPS scores (and risk for bipolar spectrum psychopathology) were 
included in the study, while maintaining a continuous distribution of HPS scores. A final sample 
of 100 women and 45 men completed the initial assessment. Mean age was 19.5 years (SD = 2.3 
years). Neither age nor sex was correlated with HPS scores (r = −.09 and −.02, respectively). 
 
Participation in the follow-up assessment 
 
All 145 original participants were invited to take part in the follow-up assessment and were 
offered $25 for their participation. One-hundred twelve participants were reassessed (77% of the 
original sample; 76 women, 36 men; mean age = 22.6 years, SD = 2.6 years). The mean interval 
between assessments was 3.1 years (SD = 0.5 years, range 1.7 to 4.8 years). Of the 33 
participants who were not reassessed, 12 declined to participate, 11 were not located, and 10 
expressed interest but never completed the reassessment. There were no significant differences 
between participants who were reassessed and those lost to attrition on HPS score, bipolar 
spectrum diagnoses, psychosocial functioning, or demographic variables, as measured at the 
initial assessment (see Table 1). 
 
 
 
Comparison of Ratings and Demographic Information From The Initial Assessment for the 
Total, Followed, and Nonfollowed Samples 
 
Materials and Procedures 
 
Measures at the initial assessment 
 
As described in Walsh, Royal, Brown, et al. (2012), participants completed interview, 
questionnaire, and ESM assessments at the initial evaluation. Interrater reliability (κ) was good at 
the initial assessment for dichotomous measures: DSM–IV–TR bipolar diagnoses, 1.00; bipolar 
spectrum diagnoses, 1.00; interview-rated hyperthymia, .83; and major depressive episodes, .92. 
Note that the interview at the initial assessment was comparable to the interview administered at 
the follow-up (described below). 
 
Participants completed the HPS at the mass-screening and at the cross-sectional assessment (2–
12 weeks apart, M = 5.5 weeks). HPS scores correlated highly across the two time points (ICC = 
.85, p < .001); therefore, mean HPS scores were used for all analyses. Coefficient alphas for the 
HPS completed at the mass-screening and cross-sectional assessments were .83 and .93, 
respectively. Note that consistent with Walsh, Royal, Brown, et al. (2012), the results were 
unchanged whether the average or individual HPS score was used as a predictor. Participants 
also completed the UPPS Impulsivity Scale (Whiteside, Lynam, Miller, & Reynolds, 2005), 
which assesses four domains of impulsive behavior: negative urgency, lack of premeditation, 
lack of perseverance, and sensation seeking. 
 
Measures at the follow-up assessment 
 
The present study included a structured interview that assessed DSM–IV–TR mood disorders, 
bipolar spectrum disorders, grandiose traits, substance use, impulsivity, borderline personality 
traits, and psychosocial functioning. Eighty-one percent of the interviews were conducted by an 
advanced graduate student in clinical psychology who had previously conducted interviews and 
ratings as part of the initial assessment. A licensed clinical psychologist and a trained 
undergraduate research assistant completed the remaining interviews. The undergraduate 
interviewer underwent extensive training, all of her interviews were supervised and reviewed by 
the first author, and she had excellent interrater reliability with the last author. All interviews 
were tape-recorded and took approximately 2 hours. Interviewers and raters at both assessments 
were unaware of participants’ HPS scores. 
 
The Structured Clinical Interview for DSM–IV (SCID-I; First, Spitzer, Gibbon, & Williams, 
1996) was used to assess lifetime mood episodes and disorders. Bipolar spectrum disorders were 
diagnosed following criteria in Akiskal (2004) and Angst et al. (2003), using information 
obtained from the SCID-I interview. The SCID-I was appropriate for diagnosing DSM–IV–TR 
bipolar disorders and bipolar III (major depression plus treatment-induced hypomania). 
Participants were interviewed for the presence of cyclothymic disorder based on DSM–IV–TR 
criteria. This assessment was also appropriate for making diagnoses of bipolar II-1/2 (major 
depression superimposed on cyclothymic temperament). Participants were interviewed for the 
presence of hyperthymic temperament, using Akiskal’s criteria, to determine diagnoses of 
bipolar IV (major depression superimposed on hyperthymic temperament). The interviews for 
cyclothymic disorder and hyperthymic temperament are presented in the supplementary 
materials. Participants were coded with “other bipolar spectrum disorder” if they reported 
hyperthymic temperament or hypomania and subthreshold depression (e.g., depressive episode 
not meeting DSM–IV–TR symptom or duration threshold or recurrent brief depression), history 
of both hyperthymic temperament and hypomania, or major depression and subthreshold 
hypomania. Following Angst et al. (2003), subthreshold hypomania was defined as a hypomanic 
episode lasting at least two days and characterized by at least three hypomanic symptoms, 
including elevated or irritable mood, or overactivity (e.g., increased goal-directed behavior, 
psychomotor activation, increased talkativeness, and/or decreased need for sleep,). Episodes 
represented a departure from one’s usual functioning, were observable to others, and could not 
be the result of a normative life experiences, alcohol or drug use, or general medical condition. 
 
Substance use disorders were diagnosed using DSM–IV–TR criteria. Quantitative ratings of 
current and lifetime heaviest substance use and impairment were made based on the scoring 
system reported in Kwapil (1996). Psychosocial functioning was rated using the global 
assessment of functioning (GAF), described in the DSM–IV–TR. Borderline personality traits 
were assessed using the International Personality Disorder Examination (IPDE; Loranger et al., 
1994). Following Eckblad and Chapman (1986), the interview included an 8-item assessment of 
grandiosity. Using a Likert scale, participants rated the likelihood that they would become 
famous or be featured on the cover of a magazine, as well as their level of ambition, creativity, 
and extent to which they felt that they were odd or different from their peers. Participants were 
also questioned about whether they had done things to call attention to themselves or considered 
themselves to be leaders or followers. Impulsivity was assessed by readministering the UPPS 
Impulsivity Scale and administering the Impulsive-Nonconformity Scale (Chapman et al., 1984). 
The latter assesses lack of concern for others, lack of respect for social and ethical standards, 
lack of remorse, lack of empathy, and unrestrained pursuit of self-gratification. Two measures of 
impulsivity were included to provide a comprehensive assessment of the construct. 
 
Results 
 
Relation of the HPS With Bipolar Spectrum Disorders 
 
Table 2 provides a summary of diagnostic outcomes at the follow-up relative to diagnostic status 
at the initial assessment. Of the 123 participants who did not receive a bipolar diagnosis at the 
initial assessment, 94 were reassessed at the follow-up. Thirteen of these 94 participants (14%) 
presented with new cases of bipolar spectrum disorders at the follow-up. Three participants 
received a DSM–IV–TR bipolar diagnosis and 10 participants received a non-DSM bipolar 
diagnosis. Twelve of the 15 participants diagnosed with a DSM–IV–TR bipolar disorder at the 
initial assessment were reassessed at the follow-up. Eight of these participants retained DSM–
IV–TR bipolar diagnoses, three were given a non-DSM bipolar diagnosis, and one no longer met 
criteria for a bipolar diagnosis. The latter participant qualified for cyclothymic disorder at the 
initial assessment; however, she exhibited prominent borderline personality traits at the follow-
up, and no longer exhibited cyclothymia. Of the seven participants diagnosed with a non-DSM 
bipolar disorder at the initial assessment, six were reassessed at the follow-up. Four of these 
participants retained non-DSM bipolar diagnoses, one transitioned to a DSM–IV–TR bipolar 
disorder, and one no longer met criteria for a bipolar diagnosis. This participant met criteria for 
bipolar IV at the initial assessment, but did not exhibit hyperthymic temperament at the follow-
up. A total of 29 of the 112 reassessed participants (26%) met criteria for a bipolar spectrum 
disorder at the follow-up. Twelve participants qualified for a DSM–IV–TR bipolar disorder and 
17 qualified for a non-DSM bipolar disorder. 
 
 
Summary of Follow-Up Assessment Diagnostic Outcomes by Diagnostic Status at the Initial 
Assessment 
 
Prediction of bipolar spectrum diagnoses 
 
HPS scores predicted total number of lifetime DSM–IV–TR bipolar and bipolar spectrum 
disorder cases at the follow-up (Table 3). As seen in Figure 1, rates of DSM–IV–TR and bipolar 
spectrum disorders increased across HPS quartiles. The HPS predicted new cases of bipolar 
spectrum disorders at the reassessment, odds ratio (OR) = 1.13, p < .01, 95% CI [1.04, 1.21]. 
Excluding the 18 participants who qualified for any bipolar disorder at the initial assessment, 13 
participants (14% of the remaining 94 participants) transitioned to a bipolar spectrum disorder. 
Thus, the HPS did not simply identify participants who qualified for bipolar spectrum disorders 
at the initial assessment, but also predicted development of new cases. However, the HPS did not 
specifically predict new cases of DSM–IV–TR bipolar disorders, OR = 1.11, p = .10, 95% CI 
[0.98, 1.27]. Excluding the 12 participants who met criteria for a bipolar disorder at the initial 
assessment, four participants (4% of the remaining 100 participants) transitioned to a DSM–IV–
TR bipolar disorder. 
 
 
Binary Logistic Regressions of the HPS Predicting Lifetime Mood Psychopathology and 
Substance Use Disorders 
 
 
Average Hypomanic Personality Score at the Initial Assessment 
 
Figure 1. Percentage of participants with bipolar spectrum disorders at the follow-up assessment 
by HPS score. 
 
Prediction of mood episodes and hyperthymic temperament 
 
The HPS predicted current hyperthymic temperament or history of hypomania, with 34% of 
participants qualifying for one or both conditions. As seen in Figure 2, 81% of the upper HPS 
quartile reported hyperthymic temperament or history of hypomania at the follow-up assessment. 
The HPS also predicted current hyperthymic temperament or history of hypomania among 
participants who did not qualify for either condition at the initial assessment, OR = 1.29, p < 
.001, 95% CI [1.13, 1.47]. The HPS was not associated with history of major depressive 
episodes, and was associated with a decreased likelihood of lifetime major depressive disorder. 
The latter presumably indicates that high HPS scorers are specifically at risk for bipolar, not 
unipolar, mood disorders. The fact that high HPS scores were associated with bipolar disorders 
was not due to the fact that HPS scores were selectively associated with depression, as major 
depressive episodes occurred at comparable rates across the HPS quartiles. The HPS did not 
predict new major depressive episodes, OR = 1.02, p = .44, 95% CI [0.97, 1.09], or new cases of 
major depressive disorder at the follow-up, OR = 1.00, p = .97, 95% CI [0.94, 1.07]. 
 
 
Average Hypomanic Personality Score at the Initial Assessment 
 
Figure 2. Percentage of participants with hypomania or hyperthymic temperament at the follow-
up assessment by HPS score. 
 
Prediction of substance use disorders 
 
The HPS predicted alcohol use diagnoses at the follow-up assessment and predicted the 
development of alcohol use disorders in participants who did not qualify for alcohol use 
disorders at the initial assessment, OR = 1.08, p < .05, 95% CI [1.01, 1.16]. Of note, 43% of 
participants with current or past alcohol use disorders were also diagnosed with a bipolar 
spectrum disorder, and all of these cases fell in the upper two quartiles of HPS scores. Similarly, 
the HPS predicted drug use diagnoses at the follow-up assessment, with 18% of participants 
meeting criteria. The HPS also predicted new cases of drug use disorders, OR = 1.08, p < .05, 
95% CI [1.00, 1.15]. Furthermore, 40% of cases with current or past drug use disorders were 
diagnosed with bipolar spectrum disorders, and the majority of these cases (75%) fell in the 
upper quartile of HPS scores and all cases fell within the upper two quartiles. 
 
Relation of the HPS With Continuous Measures of Psychopathology at the Follow-Up 
Assessment 
 
Table 4 presents the zero-order correlations of the HPS with continuous measures of 
psychopathology in the total follow-up sample and after removing participants with DSM–IV–
TR bipolar disorders. The HPS predicted interview-assessed hyperthymic temperament 
characteristics in the full sample, as well as in participants without DSM–IV–TR bipolar 
disorders. HPS scores were inversely associated with psychosocial functioning as assessed by the 
GAF in the total sample (Figure 3) and the nondisordered subsample. Given that GAF was rated 
at both assessments, the regression analysis was recomputed partialing out GAF score at the 
initial assessment. Not surprisingly, functioning at the initial assessment was significantly 
associated with functioning at the follow-up (β = .570, p < .001). However, the HPS significantly 
predicted impairment at the follow-up, over-and-above baseline GAF (β = −.188, p < .05).  
 
 
 
Zero-Order Correlations of the HPS Predicting Continuous Measures of Psychopathology 
 
 
 
Figure 3. Association of the HPS at the initial assessment with global functioning at the follow-
up assessment. 
 
As hypothesized, the HPS predicted borderline personality disorder traits, although none of the 
participants met full criteria for the diagnosis at the follow-up. Analysis of the individual traits 
indicated that the HPS predicted unstable self-image and relationships, impulsivity, transient 
paranoia/dissociation, and suicidal gestures, but not affective instability, emptiness, fear of 
abandonment, or inappropriate anger. There was good stability of borderline personality ratings 
across the initial and follow-up assessments. The number of borderline criteria met correlated .65 
and dimensional scores correlated .71 across the two assessments. However, these associations 
must be interpreted in light of the fact that the majority of the participants (75%) did not meet 
any borderline personality disorder criteria at either assessment, although the correlation of 
number of criteria met at the two assessments was .37 (a medium effect size) when limited to the 
28 participants who met at least one criterion at either assessment. 
 
The HPS predicted impulsivity symptoms, specifically impulsive-nonconformity, negative 
urgency, lack of premeditation, and sensation seeking. Additionally, the HPS predicted grandiose 
traits, including predictions of future fame or being on the cover of a magazine, as well as 
appraisals of ambition, leadership, creativity, oddness, and tendency to draw attention to oneself. 
Consistent with substance use diagnoses, the HPS predicted heaviest alcohol use and 
impairment, and current and heaviest drug use and impairment. With respect to legal problems, 
the HPS predicted history of speeding and underage drinking tickets, but not arrests. All of these 
associations were significant after removing individuals diagnosed with DSM–IV–TR bipolar 
disorders at the follow-up assessment. Thus, the results overall do not appear to be driven by a 
subset of participants with clinical disorders. 
 
Zero-order correlations also examined the extent to which the HPS predicted hyperthymic 
temperament characteristics across participants with and without bipolar spectrum disorders 
(Table 5). The HPS predicted the total score for hyperthymic temperament characteristics across 
participants in three groups: (a) total follow-up sample, (b) reduced sample with DSM–IV–TR 
bipolar disorders removed, and (c) reduced sample with all bipolar spectrum disorders removed. 
With the exception of the short sleeper characteristic, the HPS predicted hyperthymic 
temperament characteristics in the total and reduced follow-up samples. This suggests that, in 
general, the HPS taps hyperthymic temperament characteristics independent of bipolar spectrum 
diagnoses. 
 
 
 
Zero-Order Correlations of the HPS Predicting Hyperthymic Temperament Characteristics 
Across Participants With and Without Bipolar Spectrum Disorders 
 
Discussion 
 
The present research examined risk for bipolar spectrum psychopathology in a nonclinically 
ascertained sample of young adults at a 3-year follow-up assessment. The HPS predicted new 
cases of bipolar spectrum disorders, with a 14% transition rate over the follow-up period. The 
HPS appears to specifically predict bipolar mood disorders, since it was not a significant 
predictor of unipolar mood disorders. Additionally, the HPS predicted a range of symptoms and 
impairment expected to be associated with the bipolar spectrum, including grandiose traits, 
substance use disorders, borderline personality traits, and measures of impulsivity. Furthermore, 
the HPS predicted bipolar spectrum psychopathology after removing participants with DSM–IV–
TR bipolar disorders, suggesting that the results were not driven solely by a subset of participants 
with clinical disorders. 
 
At the follow-up assessment, the HPS predicted both total cases and new cases of bipolar 
spectrum disorders that developed since the initial assessment. The results are notable given that 
participants were drawn from a nonclinically ascertained sample. These findings add to the 
growing body of evidence for a broader bipolar spectrum, confirm that this spectrum is 
observable in young adults, and support the predictive validity of the HPS as a measure of the 
bipolar spectrum. Moreover, the study suggests that a young adult sample offers an ideal window 
through which to examine risk for bipolar psychopathology. 
 
As illustrated in Figure 1, the rate of DSM–IV–TR bipolar disorders was highest (27%) in the 
upper quartile of HPS scorers. Note that this rate is comparable to the 25% rate of bipolar 
disorders reported for high HPS scorers in Kwapil et al.’s (2000) 13-year prospective study. The 
HPS did not significantly predict new cases of DSM–IV–TR bipolar disorders in the present 
study. However, the overall rate of bipolar disorders and the transition rate to bipolar spectrum 
disorders are striking, given that the majority of participants in this sample have not yet reached 
the peak age of onset for clinical bipolar disorders. Using a large clinical sample of adults with 
bipolar I and II disorders across six international sites, Baldessarini et al. (2010) reported the 
median age of onset across disorders to be 25.2 years. As noted, the mean age of participants in 
the present research was 22.5 years. Therefore, we would expect continued transition to clinical 
bipolar disorders among the high HPS scorers. Of note, the mean age of participants in Kwapil et 
al.’s prospective study was 31.8 years, well beyond the median age of onset for bipolar disorders. 
 
The HPS was associated with a decreased likelihood of major depressive disorders and was not 
associated with major depressive episodes. This suggests that the HPS differentiates between 
bipolar and unipolar psychopathology, with the HPS predicting the former, but not the latter (in 
fact, only two participants in the upper quartile of HPS scores developed [unipolar] major 
depressive disorder). Note that high HPS scorers did experience major depressive episodes, but 
so did low and moderate HPS scorers. However, high HPS scorers tended to experience 
depression as part of a bipolar illness, whereas lower HPS scorers tended to experience 
depression as part of a unipolar disorder. It is important to consider that if we had not assigned 
broad bipolar spectrum disorders (especially bipolar IV diagnoses), some of these individuals 
would have been incorrectly classified with unipolar depressive disorders. Major depressive 
episodes were reported by participants across the entire range of HPS scores. However, 
participants with low HPS scores exhibited unipolar major depression (with 80% of cases of 
major depressive disorder falling in the lower two quartiles of HPS scores), whereas participants 
with high HPS scores exhibited depressive episodes as part of a bipolar presentation. Overall, 
these findings provide additional evidence that the HPS is a valid measure of risk for bipolar 
spectrum psychopathology, not simply a measure of broad risk for mood disorders. Furthermore, 
the findings do not seem to be driven by neuroticism since Walsh, Royal, Brown, et al. (2012) 
indicated that the HPS was only modestly associated with neuroticism in the present sample (r = 
.18). 
 
The HPS predicted hyperthymic temperament or history of hypomania. Eighty-one percent of 
participants in the upper quartile of HPS scores met criteria for either condition. The HPS also 
predicted hyperthymic temperament characteristics irrespective of bipolar diagnosis. 
Specifically, the HPS captured traitlike upbeat mood and high energy among individuals with 
bipolar spectrum disorders and individuals without a bipolar diagnosis. These results suggest that 
the HPS identifies a broad range of bipolar spectrum psychopathology that includes individuals 
with hyperthymic characteristics who may exhibit adaptive functioning, as well as individuals 
with hyperthymic characteristics who exhibit psychosocial impairment within the context of 
bipolar spectrum disorders. For example, the upbeat mood, sociability, versatility, decreased 
need for sleep, and high energy associated with the temperament are likely adaptive, whereas the 
aspects of the temperament associated with engagement in risky behaviors, overinvolvement in 
activities, grandiose confidence, and carefree optimism may be maladaptive. 
 
The HPS predicted measures of grandiosity, including perceptions of future fame or being on the 
cover of a magazine, and perceptions of current ambition, leadership, creativity, oddness, and 
tendency to draw attention to oneself. Participants who endorsed future fame were also 
questioned regarding how they would become famous, with anecdotal responses ranging from 
becoming a talk show host to a millionaire filmmaker. These findings replicate and expand upon 
Eckblad and Chapman’s (1986) cross-sectional results. Specifically, they suggest that the HPS 
predicts grandiose traits over time, and that grandiose traits are present across clinical and 
subthreshold bipolar presentations. Furthermore, these results build on Johnson and Carver’s 
(2006) findings that the HPS is associated with ambitious goals—and are consistent with 
findings that bipolar disorders are associated with ambitions for fame (Alloy, Bender, et al., 
2012; Johnson, Carver, & Gotlib, 2012; Johnson, Eisner, & Carver, 2009). Following Alloy, 
Bender, et al. (2012), future research should examine whether grandiose traits at this assessment 
predict the onset of bipolar spectrum disorders. 
 
The HPS predicted new cases of substance use disorders, as well as alcohol and drug use and 
impairment. These findings are consistent with studies that have documented an association 
between bipolar spectrum disorders and substance use (Angst et al., 2003, 2010; Hoertel et al., 
2013; Zimmermann et al., 2009), as well as Kwapil et al.’s (2000) finding that high HPS scorers 
had significantly higher rates of substance use disorders in comparison to a control group. It is 
worth noting that the HPS was not associated with substance use disorders at the initial 
assessment, and was generally unassociated with ratings of substance use. 
 
Consistent with Kwapil et al. (2000), the HPS predicted borderline personality traits at the 
follow-up. This finding is not surprising, given the phenomenological overlap across borderline 
and bipolar psychopathology with regard to affective instability and impulsivity (Antoniadis, 
Samakouri, & Livaditis, 2012; Coulston, Tanious, Mulder, Porter, & Malhi, 2012; Paris, 
Gunderson, & Weinberg, 2007). The HPS predicted borderline personality traits in the total 
sample and after removing participants with DSM–IV–TR bipolar disorders, although none of 
the participants met full diagnostic criteria at the follow-up for borderline personality disorder. 
This finding lends support for the HPS’ ability to differentiate between bipolar and borderline 
psychopathology, given that the HPS readily predicted bipolar spectrum disorders, but not 
borderline personality disorder. Moreover, recent research challenges the notion that borderline 
personality disorder belongs on the bipolar spectrum (Zimmerman & Morgan, 2013). The 
finding that the HPS did not predict the borderline trait of affective instability may at first seem 
surprising, but is consistent with the conjecture that affective dysregulation is different in 
borderline and bipolar spectrum disorders (Antoniadis et al., 2012; Coulston et al., 2012; Paris et 
al., 2007). For example, bipolar disorder is associated with mood changes from euthymia to 
elation or depression, whereas borderline personality disorder is associated with switches from 
euthymia to anger or anxiety (Henry et al., 2001). Additionally, environmental stressors appear 
to play a stronger role in affective responses in borderline personality disorder than bipolar 
disorders (Antoniadis et al., 2012; Paris et al., 2007). 
The present study reflects “results in progress” with respect to understanding risk for bipolar 
spectrum psychopathology and the HPS. Ideally, reassessing this sample in approximately five 
years would allow for examination of risk for bipolar spectrum psychopathology at the peak age 
of onset of bipolar disorders. Furthermore, more frequent reassessments would be optimal, given 
the cyclical and changing nature of bipolar psychopathology. Future longitudinal research could 
expand upon these findings and Kwapil et al.’s (2000) research to better elucidate risk and 
protective factors associated with the development of clinical bipolar disorders. There was 
tremendous variation in the present study with respect to mood symptoms and functioning 
associated with high scores on the HPS, ranging from participants with clinical bipolar disorders 
to participants with hyperthymic characteristics without a bipolar diagnosis. This is consistent 
with the idea that the HPS taps a spectrum of bipolar psychopathology; thus, not everyone with a 
high HPS score is expected to develop a clinical bipolar disorder. It is important to note that 
findings regarding the predictive value of the HPS may differ according to context and base rates 
of mania in the population; thus, future research should also examine validity in other 
populations (including cross-cultural validation). 
 
Affective temperaments provide a potential vehicle for examining the heterogeneity of high HPS 
scorers. Walsh, Royal, Brown, et al. (2012) reported that HPS scores were associated with 
hyperthymic and cyclothymic/irritable, but not dysthymic temperament in this sample. 
Furthermore, cyclothymic/irritable temperament predicted bipolar disorders and impairment, 
whereas hyperthymic was associated with a mix of adaptive and dysfunctional characteristics in 
the present sample (DeGeorge, Walsh, Barrantes-Vidal, & Kwapil, 2014; Walsh, Brown, 
Barrantes-Vidal, & Kwapil, 2013; Walsh, Royal, Barrantes-Vidal, et al., 2012). Note that future 
studies could examine the extent to which affective temperaments, and specific characteristics of 
these temperaments, serve as risk or protective factors for the development of bipolar disorders. 
For example, in the present research, the HPS only uniquely predicted the short sleeper 
characteristic of hyperthymic temperament in the full sample, including individuals with bipolar 
spectrum disorders. Future research could examine whether traitlike decreased need for sleep 
serves as a specific risk factor for bipolar disorders, as suggested by Gruber et al. (2009). 
Likewise, future assessments should more fully examine adaptive functioning in high HPS 
scorers and specific factors (e.g., upbeat mood) that may predict adaptive outcomes. 
 
Implications and Challenges of a Bipolar Spectrum 
 
The present findings offer support for the construct of a bipolar spectrum that extends beyond 
existing diagnostic boundaries. Identifying individuals who fall on the bipolar spectrum should 
help us better understand risk and protective factors, as well as opportunities for early 
intervention. There are challenges, however, associated with the initial step of identifying 
individuals with bipolar spectrum psychopathology. Specifically, there are contrasting opinions 
with regard to how to define the bipolar spectrum (Kuiper, Curran, & Malhi, 2012; Mazza, Di 
Nicola, Janiri, & Bria, 2013; Strakowski, Fleck, & Maj, 2011). The present study included 
Akiskal’s (2004) bipolar spectrum disorders; however, epidemiological studies of subthreshold 
bipolarity have generally excluded assessment of affective temperaments. Rather, 
epidemiological research has attempted to validate a subthreshold bipolar disorder using 
inconsistent definitions. We are ultimately left with evidence for a broader bipolar spectrum, but 
its boundaries remain quite murky. This lack of consensus on an operational definition for the 
bipolar spectrum has only increased the controversy surrounding the construct—and makes the 
discussion of early interventions challenging and only speculative. The present research adds to 
the evidence-base for a bipolar spectrum that extends beyond existing diagnostic nomenclature, 
and offers support for the validity of the HPS as a tool for identifying individuals at risk at the 
group level. Ultimately, accurate identification of individuals who fall on the bipolar spectrum 
will aid understanding of risk and protective factors, as well as the underlying etiology of bipolar 
disorders. Future research should specifically examine the role of moderating factors such as 
impulsivity and substance use that may increase risk of transition into clinical disorders. 
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